• Blog
  • Prefilled Syringes Market Analysis | 2022-2028

    Prefilled Syringes Market Analysis | 2022-2028

    Prefilled Syringes Market Analysis | 2022-2028
    Report code - SR2297 Delivery - 2 Weeks
    Prefilled Syringes Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth O See more...

    Market Insights

    The Prefilled Syringes Market was estimated at US$ 5.3 billion in 2021 and is expected to grow at a CAGR of 10.92% during 2022-2028 to reach US$ 10.98 billion in 2028.

     

    Wish to get a free sample? Register Here

    What are prefilled syringes?

    Prefilled syringes are ready-to-use medical devices designed to contain a single dose of medication in a pre-measured and pre-loaded form. They consist of a syringe barrel, plunger, and a needle or needle cover. These syringes are filled with specific doses of liquid medications, vaccines, or therapeutic substances, streamlining the administration process for healthcare professionals and patients. Prefilled syringes minimize dosing errors, enhance convenience, and reduce the risk of contamination. They are widely used in various medical settings, including hospitals, clinics, and home care, improving accuracy and efficiency in drug delivery while maintaining patient safety.

    Market Dynamics

    The primary reasons driving the market expansion are an increase in the demand for effective and user-friendly drug delivery systems and an increase in the efforts made by healthcare professionals to lower hospital errors. During the projected period, the market expansion is anticipated to be driven by the rapid development of feature-rich devices with underlying technology breakthroughs enabling safer and more convenient self-injections for patients.

    Growth in the business is anticipated to be boosted by a sharp increase in the development of biological medicines. Due to their greater effectiveness and patient safety with fewer side effects, biological medicines, and therapeutic vaccines are quickly replacing conventional treatment choices. The ongoing availability of biologic pharmaceuticals has increased the need for creative packaging techniques to preserve the potency of these exceedingly unstable medications. The parenteral administration of more than 60% of biological medications now in development is preferable since any interactions with food or digestive enzymes cause them to degrade. Prefilled syringes are therefore thought to be the best type of storage for such medications. Additionally, the expansion of the biologics sector is fueling the market growth.

    Needlestick wounds have the potential to be harmful because they can spread deadly illnesses like HIV and hepatitis. For instance, 37.7 million [30.2 million-45.1 million] people worldwide were HIV positive in 2020, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS), as of June 2021. The same report also states that as of June 2021, 28.2 million people had access to antiretroviral medication, which is expected to promote industry growth. Additionally, there is a significant risk of needle stick injuries during dose preparation for both patients and medical professionals. For instance, Occupational Safety and Health Administration (OSHA) estimates that in March 2021, two million healthcare personnel (out of a total of 35 million) experience accidental needle-stick wounds every year, costing them an estimated $1.5 billion. Such measures boost the market demand.

    Additionally, according to the Centers for Disease Control and Prevention (CDC), employing safety precautions like prefilled syringes in hospitals might cut down on injuries caused by sharps by 60-88%. This is because using prefilled syringes can readily lessen these injuries as their use avoids the need for numerous dose preparation stages and allows for simple disposal. Innovative improvements like buried needles are important in the case of self-injection devices in reducing such injuries, leading to enhanced patient convenience. Prefilled syringes offer safety without the increased cost, therefore their use is anticipated to rise in the coming years.

    Prefilled Syringes Market Report Overview

    Market Size in 2028

    US$ 10.98 billion

    Market Size in 2021

    US$ 5.3 billion

    Market Growth (2022-2028)

    10.92% CAGR

    Base Year of Study

    2021

    Trend Period

    2016-2020

    Forecast Period

    2022-2028

     

    Several investments/guidelines in the market have been directed in recent years, which would boost the overall market. Some of them are:

    • Growing government spending on modern syringe manufacturing will soon fuel industry expansion. For instance, in March 2022, USD 84.53 million will be invested in Hungary through Schott and the government to meet the rising demand for pre-fillable glass syringes around the world. By the time it is finished in 2024, the extension should be able to meet the product's future demand.

    Segments Analysis

    Segmentations

    List of Sub-Segments

    Dominant and Fastest-Growing Segments

    Application-Type Analysis

    Anaphylaxis, Rheumatoid Arthritis, Diabetes, Others

    The diabetes market segment dominated the sector when looking at the range of applications.

    Type Analysis

    Disposable Prefilled Syringes, Reusable Prefilled Syringes

    The disposable prefilled syringes market segment had the biggest share in 2021.

    Material-Type Analysis

    Glass Prefilled Syringes, Plastic Prefilled Syringes

    The glass syringes category led the market in 2021.

    Regional Analysis

    North America, Europe, Asia-Pacific, and Rest of the World

    Europe held the largest market share for prefilled syringes in 2021.

     

    By Application Type

    The market is segmented into anaphylaxis, rheumatoid arthritis, diabetes, and others. The diabetes market segment dominated the sector when looking at the range of applications. Numerous factors, including a sizable patient population, a rise in the prevalence of diabetes, and the demand for efficient and safer insulin delivery devices, are anticipated to keep this market at the top during the projection period. For instance, the International Diabetes Federation research estimates that there will be 537 million persons with diabetes worldwide (aged 20 to 79) in 2021, rising to roughly 783 million by 2045.

    By Type

    The market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. Due to its numerous uses, the disposable prefilled syringes market segment had the biggest share in 2021. These devices lessen the danger of contamination, which is expected to increase demand for them. Needlestick injuries are brought on by risky practices such as repeatedly using a prefilled syringe and needle without taking the necessary safety procedures as advised by medical authorities. Additionally, while conventional disposable prefilled syringes protect the receiver, they do not guarantee patient safety. Therefore, a strong desire for patient safety has led to an increase in the use of disposable equipment in healthcare facilities including hospitals and nursing homes. These elements should accelerate segment growth.

    By Material Type

    The prefilled syringes market has been divided into glass prefilled syringes and plastic prefilled syringes. The glass syringes category led the market in 2021. Glass syringes are currently the industry standard for prefilled syringes. Glass syringes are simple to use and, for medical experts, check for any particulate contaminants. Glass is a trustworthy choice because its clarity and inertness guarantee the purity of the dose. However, it is projected that the use of glass syringes in the worldwide prefilled syringes market will be limited by rising consumer desire for safer goods that enable self-administration of medication and increased glass fragility during shipping.

    Regional Analysis

    The prefilled syringes market is broken down geographically into geographies, namely North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Due to considerations like the increasing preference of healthcare professionals for prefilled injectable devices to reduce needle-related injuries, Europe held the largest market share for prefilled syringes in 2021. Major market companies including Gerresheimer AG, SCHOTT Group, Stevanato Group, Haselmeier AG, and Owen Mumford Ltd. are also present in the area. Over time, several businesses have increased their local presence. Due to this circumstance, the market has become more competitive in the area, making it challenging for new competitors to enter. Due to these businesses' global expansion and dominance of the market, Europe receives the majority of global revenue. the use of single-use medical products to reduce infections and other government initiatives fuels the market growth.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    The following are the key players in the prefilled syringes market:

    • Abbott
    • Baxter
    • Bayer AG
    • BD 
    • Gerresheimer AG
    • Haselmeier AG
    • Medtronic plc
    • Nipro Medical Corporation
    • Owen Mumford
    • Schott Group
    • Terumo Medical Corporation
    • Unilife Corporation
    • Vetter Pharma GmbH

    Prefilled syringes are receiving an increasing number of regulatory agency approvals from the U.S., FDA, and EU, combined with an expanding market, which is expected to significantly aid industry growth.

    For instance,

    • In Asia, the safety device known as the 1mL UniSafe for pre-filled syringes was approved in September 2022 by Owen Mumford Pharmaceutical Services, a division of Owen Mumford Ltd. Additionally approved by European regulators, 1mL UniSafe is now marketed as a combination product with a rheumatoid arthritis medication. Additionally, 1mL UniSafe is a ground-breaking, patented safety mechanism for prefilled syringes that offers several advantages to pharmaceutical companies and their patients, which is projected to boost the safety of patients.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Prefilled Syringes Market 

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com

    Frequently Asked Questions (FAQs)

    The prefilled syringes market is expected to grow at a CAGR of 10.92% during 2022-2028.

    The prefilled syringes market is likely to reach US$ 10.98 billion in 2028.

    The primary reasons driving the market expansion are an increase in the demand for effective and user-friendly drug delivery systems and an increase in the efforts made by healthcare professionals to lower hospital errors. During the projected period, the market expansion is anticipated to be driven by the rapid development of feature-rich devices with underlying technology breakthroughs enabling safer and convenient self-injections for patients.

    Europe is estimated to remain the dominant region in the prefilled syringes market in the foreseeable future. The region's growth factors can be linked to considerations like the increasing preference of healthcare professionals for prefilled injectable devices to reduce needle-related injuries.

    The diabetes market segment is estimated to remain dominant in the market in the coming years when looking at the range of applications.

    The key players in the prefilled syringes market are Abbott, Baxter, Bayer AG, BD, Gerresheimer AG, Haselmeier AG, Medtronic plc, Nipro Medical Corporation, Owen Mumford, Schott Group, Terumo Medical Corporation, Unilife Corporation, and Vetter Pharma GmbH.

    The market is studied from 2016-2028.